New York, January 9, 2025: The world’s most adopted healthcare AI company, Qure.ai, has appointed a new Chief Commercial Officer to oversee and expand global sales and business development strategy. Based in New York, Jim Mercadante joins a growing commercial and operations team to consolidate growing momentum and orchestrate further success.
With an AI deployment footprint in more than 90 countries, Qure.ai has seen exponential growth in Asia, Africa, the Middle East and Europe over the last 8 years, with demand for its healthcare AI and digital health tools now growing in North and South America.
Jim Mercadante brings a wealth of commercial leadership, sales, business growth and strategic marketing experience with leadership positions at Abbott, Johnson and Johnson, GE, Terumo and most recently Rapid AI. His leadership will be instrumental as Qure.ai builds on the impetus created by its recent Series D funding, which will drive growth across the US and other geographies, support ongoing innovation in AI and digital health solutions, and explore complementary acquisitions.
Prashant Warier, Co-Founder and CEO of Qure.ai states, “We warmly welcome Jim Mercadante and look forward to his leadership to advance our global sales strategy, strengthen partnerships with healthcare providers and channel partners, plus optimize commercial operations for growth globally. He will be based in our USA office but travel extensively to advance our worldwide sales strategy, consolidate existing customer successes and optimise commercial operations.”
Jim Mercadante, Chief Commercial Officer of Qure.ai states, “Qure.ai stands out for its exceptional people, cutting-edge technology, and clear vision for the future of healthcare. I’m excited to contribute to the company’s growth as we continue to expand globally and develop AI solutions that address critical healthcare challenges.”
Notes to editors:
Images to accompany news story:
Jim Mercadante has been appointed as Chief Commercial Officer at Qure.ai
